Gender-based outcomes among patients with diabetes mellitus after percutaneous coronary intervention in the drug-eluting stent era

International Heart Journal

Volumn 52, Issue 6, 2011, Pages 348-352

  Ogita, Manabu ^a   Miyauchi, Katsumi ^a   Dohi, Tomotaka ^a   Wada, Hideki ^a   Tuboi, Shuta ^a   Miyazaki, Tadashi ^a   Nishino, Akihisa ^a   Yokoyama, Takayuki ^a   Kojima, Takahiko ^a   Yokoyama, Ken ^a   Kurata, Takeshi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Coronary intervention; Diabetes mellitus; Drug eluting stent; Gender

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TARGET LESION REVASCULARIZATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84255169318     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.52.348     Document Type: Article

References (25)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241: 2035-8.
2. Kasai T, Miyauchi K, Kajimoto K, Kubota N, Kurata T, Daida H. Influence of diabetes on >10-year outcomes after percutaneous coronary intervention. Heart Vessels 2008; 23: 149-54.
3. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265: 627-31.
4. Natarajan S, Liao Y, Cao G, Lipsitz SR, McGee DL. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 2003; 163: 1735-40.
5. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-8. (Review)
6. West NE, Ruygrok PN, Disco CM, et al. Clinical and angiographical predictors of restenosis after stent deployment in diabetic patients. Circulation 2004; 109: 867-73.
7. Elezi S, Katrati A, Pache J, et al. Diabetes mellitus and clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32: 1866-73.
8. Jensen LO, Thayssen P, Mintz GS, et al. Intravascular ultrasound assessment of remodeling and reference segment plaque burden in type-2 diabetic patients. Eur Heart Journal 2007; 28: 1759-64.
9. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Eng J Med 2002; 346: 1773-80.
10. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Eng J Med 2006; 355: 1105-13.
11. Daemen J, Garcia-Garcia HM, Kukreja N, et al. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J 2007; 28: 26-32.
12. Garg P, Normand SL, Silbaugh TS, et al. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation 2008; 118: 2277-85.
13. Cowley MJ, Mullin SM, Kelsey SF, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA registry. Circulation 1985; 71: 90-7.
14. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation 1993; 87: 720-7.
15. Thompson CA, Kaplan AV, Friedman BJ, et al. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era. Catheter Cardiovasc Interv 2006; 67: 25-31.
16. Onuma Y, Kukreja N, Daemen J, et al. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease. JACC Cardiovasc Interv 2009; 2: 603-10.
17. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.
18. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004; 27: 2898-904.
19. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women in diabetes, 1971 to 2000. Ann Intern Med 2007; 147: 149-55.
20. Chandra NC, Ziegelstein RC, Roger WJ, et al. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998; 158: 981-8.
21. Lanskey AJ, Costa RA, Mooney M, et al. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol 2005; 45: 1180-5.
22. Solinas E, Nikolsky E, Lansky AJ, et al. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol 2007; 50: 2111-6.
23. Champney KP, Veledar E, Klein M, et al. Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time. Am Heart J 2007; 153: 970-8.
24. Kambara H, Yamazaki T, Hayashi D, et al. Gender differences in patients with coronary artery disease in Japan: the Japanese Coronary Artery Disease Study (the JCAD study). Circ J 2009; 73: 912-7.
25. Funakoshi S, Furukawa Y, Ehara N, et al. Clinical characteristics and outcomes of Japanese women undergoing coronary revascularization therapy. Circ J 2011; 75: 1358-67.